C. Imrie et al. / Journal of Organometallic Chemistry 689 (2004) 1617–1622
1621
304, 303 (Mþ, 100), 302, 238, 182, 121, 91, 56. Anal.
Calc. for C18H17FeN: C, 71.4; H, 5.6; N, 4.6; [Mþ],
303.071039. Found: C, 70.9; H, 5.3; N, 4.6%; [Mþ],
303.071989.
(3H, t, CH3); 13C NMR (CDCl3) 159.91, 157.64, 146.12,
122.08, 115.37, 81.20, 71.48, 69.62, 69.27, 68.71, 32.35,
30.09, 30.03, 29.85, 29.79, 29.75, 26.48, 23.12, 14.56; m=z
503, 502, 501 (Mþ, 100), 417, 305, 304, 221, 214, 186,
121, 109, 69, 57, 43. Anal. Calc. for C31H43FeNO: C,
74.3; H, 8.6; N, 2.8; [Mþ], 501.269405. Found: C, 74.6;
H, 9.0; N, 2.6; [Mþ], 501.269387.
4.3.3. 4-Nitro-N-(ferrocenylmethylidene)aniline 4 (X ¼
4-NO2)
The general procedure was followed using ferrocene-
carboxaldehyde (200 mg, 0.93 mmol) and 4-nitroaniline
(129 mg, 0.93 mmol) except that the reaction mixture
was warmed to 50 °C in a water bath. The product was
isolated as a red solid and was recrystallized from cold
anhydrous methanol (286 mg, 92%); m.p. 183–185 °C;
IR (KBr cmꢀ1) 3102, 2914, 1631, 1593, 1578, 1506, 1341,
1223, 1111, 1052, 867, 828, 742, 703, 650, 492; 1H NMR
(CDCl3) 8.37 (1H, s, CHN), 8.26 (2H, d, J 7.7, ArH),
7.20 (2H, d, J 7.6, ArH), 4.84 (2H, s, C5H4), 4.60 (2H, s,
C5H4), 4.29 (5H, s, C5H5); 13C NMR (CDCl3) 164.51,
158.98, 145.32, 125.51, 121.48, 79.79, 72.62, 70.07,
69.93; m=z 335, 334 (Mþ, 100), 323, 288, 222, 214, 186,
167, 139, 121, 56. Anal. Calc. for C17H14FeN2O2: [Mþ],
334.040467. Found: [Mþ], 334.040503.
4.3.6. 4-Ferrocenyl-N-(ferrocenylmethylidene)aniline 4
(X ¼ 4-Fc)
The general procedure was followed using ferrocene-
carboxaldehyde (100 mg, 0.47 mmol) and 4-ferroceny-
laniline (130 mg, 0.47 mmol). The product was isolated
as a red solid and was recrystallized from cold anhy-
drous methanol (211 mg, 95%); m.p. 211–212 °C; IR
(KBr cmꢀ1) 3050, 1619, 1598, 1525, 1460, 1103, 1052,
1
1012, 894, 834, 512, 492; H NMR (CDCl3) 8.41 (lH, s,
CHN), 7.50 (2H, d, J 7.7, ArH), 7.13 (2H, d, J 7.8,
ArH), 4.83 (2H, s, C5H4), 4.67 (2H, s, C5H4), 4.52 (2H,
s, C5H4), 4.34 (2H, s, C5H4), 4.28 (5H, s, C5H5), 4.07
(5H, s, C5H5); 13C NMR (CDCl3) 160.85, 150.91,
136.80, 127.18, 121.18, 85.66, 81.03, 71.71, 70.02, 69.71,
69.44, 69.30, 66.75; m=z 474, 473 (Mþ), 471, 278, 277
(100), 275, 156, 121, 49. Anal. Calc. for C27H23Fe2N: C,
68.6; H, 4.9; N, 3.1; [Mþ], 473.052928. Found: C, 67.9;
H, 4.5; N, 3.1; [Mþ], 473.052125.
4.3.4. 4-Octyloxy-N-(ferrocenylmethylidene)aniline 4 (X ¼
4-OC8H17)
The general procedure was followed using ferrocene-
carboxaldehyde (100 mg, 0.47 mmol) and 4-octylox-
yaniline (104 mg, 0.47 mmol). The product was isolated
as a red solid and was recrystallized from cold anhydrous
4.4. Preparation of ferrocenylimines derived from 4-
formylphenylferrocene
methanol (182 mg, 93%); m.p. 71–72 °C; IR (KBr cmꢀ1
)
2921, 2861, 1631, 1512, 1473, 1302, 1249, 1190, 1117,
4.4.1. 4-Tetradecyloxy-N-[4-(4-ferrocenyl)benzylidene]
aniline 5 (X ¼ 4-OC14H29)
1
1038, 1005, 834, 736, 532, 505, 479; H NMR (CDCl3)
8.35 (1H, s, CHN), 7.15 (2H, d, J 8.6, ArH), 6.92 (2H, d,
J 8.6, ArH), 4.80 (2H, s, C5H4), 4.48 (2H, s, C5H4), 4.26
(5H, s, C5H5), 3.99 (2H, t, OCH2), 1.80 (2H, m, CH2),
1.47–1.29 (10H, m, CH2 ꢁ 5), 0.92 (3H, t, CH3); 13C
NMR (CDCl3) 159.92, 157.64, 146.10, 122.07, 115.38,
81.17, 70.06, 69.62, 69.27, 68.72, 32.23, 29.79, 29.73,
29.66, 26.47, 23.07, 14.52; m=z 418, 417 (Mþ, 100), 415,
305, 304, 221, 186, 121, 109, 43. Anal. Calc. for
C25H31FeNO: C, 72.0; H, 7.5; N, 3.3; [Mþ], 417.175504.
Found: C, 72.3; H, 7.3; N, 3.6; [Mþ], 417.175484.
The general procedure was followed as in 4.2 using 4-
formylphenylferrocene (100 mg, 0.34 mmol) and 4-tet-
radecyloxyaniline (104 mg, 0.34 mmol). The product was
isolated as an orange solid and was recrystallized from
cold anhydrous methanol (188 mg, 96%); m.p. 110–
112 °C; IR (KBr cmꢀ1) 2933, 2861, 1625, 1607, 1508,
1
1473, 1297, 1256, 1174, 1027, 845, 722, 546; H NMR
(CDCl3) 8.47 (lH, s, CHN), 7.82 (2H, d, J 8.3, ArH), 7.58
(2H, d, J 8.2, ArH), 7.25 (2H, d, J 8.8, ArH), 6.94 (2H, d,
J 8.8, ArH), 4.75 (2H, t, J 1.8, C5H4), 4.41 (2H, t, J 1.8,
C5H4), 4.07 (5H, s, C5H5), 4.01 (2H, t, J 5.6, OCH2), 1.80
(2H, m, CH2), 1.59–1.28 (22H, m, CH2 ꢁ 11), 0.90 (3H, t,
CH3); 13C NMR (CDCl3) 158.55, 158.15, 145.36, 143.37,
134.46, 129.07, 126.50, 122.53, 115.37, 84.36, 70.18,
69.97, 68.69, 67.11, 32.34, 30.08, 30.01, 29.83, 29.78,
29.72, 26.47, 23.11, 14.55; m=z 578, 577 (Mþ), 418, 417,
305, 290, 109 (100), 108, 69, 43. Anal. Calc. for
C37H47FeNO: C, 77.0; H, 8.2; N, 2.4; [Mþ], 577.300705.
Found: C, 77.3; H, 8.2; N, 2.2; [Mþ], 577.300679.
4.3.5. 4-Tetradecyloxy-N-(ferrocenylmethylidene)aniline
4 (X ¼ 4-OC14H29)
The general procedure was followed using ferrocene-
carboxaldehyde (100 mg, 0.47 mmol) and 4-tetradecy-
loxyaniline (143 mg, 0.47 mmol). The product was
isolated as a yellow crystalline solid and was recrystal-
lized from cold anhydrous methanol (221 mg, 94%);
m.p. 77–78 °C; IR (KBr cmꢀ1) 3097, 2923, 2872, 1631,
1502, 1472, 1244, 1103, 1015, 840, 798, 728, 505, 488; 1H
NMR (CDCl3) 8.35 (1H, s, CHN), 7.15 (2H, d, J 8.6,
ArH), 6.92 (2H, d, J 8.6, ArH), 4.80 (2H, s, C5H4), 4.48
(2H, s, C5H4), 4.25 (5H, s, C5H5), 3.98 (2H, t, OCH2),
1.82 (2H, m, CH2), 1.48–1.29 (22H, m, CH2 ꢁ 11), 0.91
4.4.2. 4-Ferrocenyl-N-[4-(4-ferrocenyl)benzylidene]ani-
line 5 (X ¼ 4-Fc)
The general procedure was followed as in 4.2 using
4-formylphenylferrocene (100 mg, 0.34 mmol) and